文献速递乳腺癌妇科肿瘤消化系统肿瘤

快速生长的癌症是否更具致死性?

Are rapidly growing cancers more lethal?
PubMed 文献 · Eur J Cancer · 2016-12-30

该综述通过系统层面分析细胞内与细胞间信号网络,并结合乳腺、宫颈和大肠癌的筛查数据,未发现支持「快速生长肿瘤更易转移」这一观点的证据,提示应重新审视该固有观念及长度偏倚采样在癌症筛查中的影响。

要点

  • 系统层面信号网络分析提示快速生长与转移常为复杂整合分子事件的不同结局。
  • 来自乳腺、宫颈和大肠癌的筛查数据未支持快速生长癌症更易转移的理论。
  • 作者认为应重新考虑主流观点及长度偏倚采样在癌症筛查中的影响。

核心结论

  • 来自人类的证据未支持快速生长的癌症更易转移这一理论,主流观点应被重新考虑。

研究设计与样本

  • 研究对细胞内与细胞间信号网络进行了详尽的系统层面分析,并综述了限于乳腺癌、宫颈癌和大肠癌的所有可用人类数据。

主要发现

  • 系统层面信号网络分析表明快速生长与转移常为复杂整合分子事件的不同结局。
  • 来自人类的证据主要源自筛查干预,因筛查阴性后短期内临床出现的间期癌平均比筛查未发现的癌症生长更快。
  • 限于乳腺癌、宫颈癌和大肠癌的可用人类数据未提供支持快速生长癌症更易转移的证据。

临床怎么用

  • 原文未据此给出推荐。
  • 作者认为应重新考虑主流观点以及长度偏倚采样在癌症筛查中的影响。
  • 作者认为这些发现不支持对间期癌比非间期癌进行更积极的治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The view, that rapidly growing tumours are more likely than slow-growing tumours to metastasize and become lethal, has remained almost axiomatic for decades. Unaware of any solid evidence supporting this view, we undertook an exhaustive system-level analysis of intra- and intercellular signalling networks. This analysis indicated that rapid growth and metastasis are often different outcomes of complex integrated molecular events. Evidence from humans can be derived chiefly from screening interventions because interval cancers that surface clinically shortly after a negative screening test are, on average, more rapidly growing than cancers not detected by screening. We reviewed all available data limited to cancers of the breast, cervix and large bowel. The evidence from humans provides no support for the theory that rapidly growing cancers are more prone to metastasize. These findings indicate that the prevailing view should be reconsidered, as should the impact of length-biased sampling in cancer screening, and the findings provide no support for treating interval cancers more aggressively than non-interval cancers.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Adami HO, Csermely P, Veres DV, et al. Are rapidly growing cancers more lethal? Eur J Cancer. 2016. PMID: 28042992. doi:10.1016/j.ejca.2016.11.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。